S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
Kroger shares are begging to be bought 
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Behind the tech boom: Big price leaders selectively laying off
Dallas Mavericks purchase turns LVS stock into a cheaper bet
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
These biotechs targeting multiple neurodegenerative diseases
Earnings propel Crowdstrike, cybersecurity sector, to new highs

Cambridge Cognition Share Price, News & Analysis (LON:COG)

GBX 54.50
0.00 (0.00%)
(As of 12/1/2023 ET)
Compare
Today's Range
53.94
54.50
50-Day Range
51
94.80
52-Week Range
50.55
129.74
Volume
5,032 shs
Average Volume
52,133 shs
Market Capitalization
£19.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

COG stock logo

About Cambridge Cognition Stock (LON:COG)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

COG Stock Price History

COG Stock News Headlines

All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Cambridge Cognition Wins Contract Valued at GBP1Mln
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
See More Headlines
Receive COG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/22/2020
Today
12/02/2023

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Net Income
£-3,740,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£12.77 million
Cash Flow
GBX 12.65 per share
Book Value
GBX 3 per share

Miscellaneous

Free Float
N/A
Market Cap
£19.04 million
Optionable
Not Optionable
Beta
1.01
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Matthew William Stork (Age 55)
    CEO & Director
    Comp: $342k
  • Mr. Stephen Daniel Symonds (Age 48)
    CFO & Executive Director
    Comp: $203.31k
  • Mr. John Hammond
    Co-Founder
  • Mr. Nick Taptiklis
    Head of Technology Strategy
  • Ms. Francesca Cormack Ph.D.
    Chief Scientist
  • Mr. Simon Merritt
    Marketing and Communications Director
  • Dr. Lisa Elizabeth Nolan Ph.D. (Age 61)
    Vice President Business Development
  • Ms. Nicky Ackerley
    Global HR Director
  • Prof. Trevor Robbins
    Senior Consultant
  • Prof. Barbara Sahakian FMedSci
    FBPsS, Senior Consultant














COG Stock Analysis - Frequently Asked Questions

How have COG shares performed in 2023?

Cambridge Cognition's stock was trading at GBX 114 at the beginning of the year. Since then, COG stock has decreased by 52.2% and is now trading at GBX 54.50.
View the best growth stocks for 2023 here
.

How were Cambridge Cognition's earnings last quarter?

Cambridge Cognition Holdings Plc (LON:COG) announced its quarterly earnings data on Tuesday, September, 22nd. The company reported ($1.50) earnings per share (EPS) for the quarter. Cambridge Cognition had a negative net margin of 29.25% and a negative trailing twelve-month return on equity of 630.55%.

What other stocks do shareholders of Cambridge Cognition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambridge Cognition investors own include Interserve (IRV), Alio Gold Inc. (ALO.TO) (ALO), Concepta PLC (CPT.L) (CPT), European Metals (EMH), IntelGenx Technologies (IGXT), Oxford Biomedica (OXB), Syneos Health (SYNH), Travelers Companies (TRV), Amryt Pharma (AMYT) and AltynGold (ALTN).

How do I buy shares of Cambridge Cognition?

Shares of COG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:COG) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -